X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (608) 608
Publication (49) 49
Book Review (14) 14
Book Chapter (8) 8
Newspaper Article (8) 8
Book / eBook (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (418) 418
index medicus (377) 377
female (241) 241
male (222) 222
middle aged (202) 202
osteoprotegerin (192) 192
plasma (154) 154
aged (148) 148
adult (120) 120
risk factors (120) 120
osteoprotegerin - blood (117) 117
animals (115) 115
plasma osteoprotegerin (108) 108
biomarkers - blood (95) 95
research (93) 93
atherosclerosis (92) 92
medicine (90) 90
endocrinology & metabolism (89) 89
inflammation (84) 84
biomarkers (83) 83
bone (76) 76
multiple myeloma (75) 75
research article (74) 74
diabetes (72) 72
mortality (72) 72
cytokines (71) 71
expression (71) 71
proteins (69) 69
oncology (68) 68
studies (68) 68
cardiovascular disease (67) 67
vascular calcification (67) 67
osteoporosis (66) 66
receptor activator (65) 65
hematology (64) 64
physiological aspects (64) 64
analysis (63) 63
disease (63) 63
calcification (62) 62
multidisciplinary sciences (62) 62
gene expression (57) 57
health aspects (57) 57
cell biology (56) 56
medicine, research & experimental (56) 56
biocompatibility (55) 55
immunology (54) 54
science (53) 53
care and treatment (52) 52
enzyme-linked immunosorbent assay (50) 50
mice (50) 50
coronary-artery-disease (49) 49
prognosis (49) 49
bone marrow (48) 48
cardiovascular-disease (48) 48
kappa-b ligand (48) 48
patients (47) 47
serum osteoprotegerin (46) 46
platelet-rich plasma (45) 45
musculoskeletal diseases (44) 44
osteoblasts (44) 44
cardiac & cardiovascular systems (43) 43
cardiovascular diseases (41) 41
growth factors (41) 41
in-vitro (41) 41
biomedical materials (40) 40
multiple myeloma - pathology (40) 40
postmenopausal women (40) 40
review (40) 40
apoptosis (39) 39
biology (39) 39
c-reactive protein (39) 39
genetic aspects (39) 39
cancer (38) 38
risk (38) 38
stem cells (38) 38
aged, 80 and over (37) 37
article (37) 37
cells, cultured (37) 37
development and progression (37) 37
metabolism (36) 36
prospective studies (36) 36
disease progression (35) 35
bone density (34) 34
case-control studies (34) 34
cells (34) 34
dentistry (34) 34
differentiation (34) 34
medical research (34) 34
osteoprotegerin - metabolism (34) 34
signal transduction (34) 34
smooth-muscle-cells (34) 34
type 2 diabetes (34) 34
article subject (33) 33
association (32) 32
rankl (32) 32
rodents (32) 32
bones (31) 31
diabetes mellitus, type 2 - blood (31) 31
insulin-resistance (31) 31
ligands (31) 31
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Endocrinology, ISSN 1687-8337, 2015, Volume 2015, pp. 564934 - 15
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 06/2012, Volume 27, Issue 6, pp. 2571 - 2575
Background. In patients with chronic kidney disease, vascular calcification contributes to increased cardiovascular (CV) morbidity and mortality. CV risk... 
Cardiovascular disease | Mortality | Renal transplantation vascular calcification | Osteoprotegerin | BONE-DENSITY | cardiovascular disease | ELEVATED OSTEOPROTEGERIN | EVENTS | renal transplantation vascular calcification | CORONARY-ARTERY CALCIFICATIONS | VASCULAR CALCIFICATION | ATHEROSCLEROSIS | TRANSPLANTATION | ALL-CAUSE MORTALITY | DIABETIC-PATIENTS | PLASMA OSTEOPROTEGERIN | mortality | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | osteoprotegerin | Kidney Failure, Chronic - mortality | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Fatty Acids, Monounsaturated - therapeutic use | Vascular Calcification - etiology | Graft Rejection - mortality | Cardiovascular Diseases - mortality | Vascular Calcification - mortality | Adult | Female | Vascular Calcification - diagnosis | Cardiovascular Diseases - diagnosis | Biomarkers - metabolism | Cardiovascular Diseases - etiology | Enzyme-Linked Immunosorbent Assay | Kidney Failure, Chronic - drug therapy | Risk Factors | Graft Rejection - etiology | Survival Rate | Graft Rejection - diagnosis | Anticholesteremic Agents - therapeutic use | Kidney Failure, Chronic - complications | Creatinine - blood | Indoles - therapeutic use | Kidney Transplantation - mortality | Aged | Osteoprotegerin - metabolism | Kidney Transplantation - adverse effects | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Cancer Causes & Control, ISSN 0957-5243, 6/2018, Volume 29, Issue 6, pp. 507 - 517
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 12/2010, Volume 33, Issue 12, pp. 2561 - 2566
Journal Article
Experimental and therapeutic medicine, ISSN 1792-0981, 07/2019, Volume 18, Issue 1, pp. 358 - 365
Platelet-rich fibrin (PRF) is a platelet concentrate derived from complete autologous blood rich in growth factors in the fibrin matrix. Although PRF has been... 
MEDICINE, RESEARCH & EXPERIMENTAL | DEFECTS | MC3T3-E1 | bone defect-healing | platelet-rich fibrin | PLASMA PRP | OSTEOCLASTOGENESIS | IN-VITRO | osteoblastic differentiation | CONCENTRATED GROWTH-FACTOR | ENHANCEMENT | BONE REGENERATION | DIFFERENTIATION | STROMAL CELLS | osteoprotegerin | EXPRESSION
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 07/2018, Volume 78, Issue 3, pp. 362 - 366
BACKGROUND:The contributions of the receptor activator of nuclear factor kappa-B ligand (RANKL)/osteoprotegerin (OPG) axis to cardiovascular and bone disease... 
Plasma | Therapy | Spine | Ritonavir | Clinical trials | Infections | Osteoprotegerin | Tenofovir | Randomization | Antiretroviral agents | Human immunodeficiency virus--HIV | Biocompatibility | Carotid artery | TRANCE protein | Emtricitabine | Ribonucleic acid--RNA | Patients | Morbidity | Antiretroviral therapy | Hip | Correlation analysis | Ligands | Bone mineral density | Plasma levels | Antiviral drugs
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2001, Volume 98, Issue 20, pp. 11581 - 11586
Bone destruction, caused by aberrant production and activation of osteoclasts, is a prominent feature of multiple myeloma. We demonstrate that myeloma... 
Biological Sciences | Cytokines | Stromal cells | Cell lines | Coculture techniques | Bone marrow | Plasma cells | Antibodies | Bones | Mice | Heterologous transplantation | GROWTH-FACTOR-BETA | TGF-BETA | COLONY-STIMULATING FACTOR | TRANCE | B-LYMPHOPOIESIS | MULTIDISCIPLINARY SCIENCES | OSTEOCLASTOGENESIS-INHIBITORY FACTOR | OSTEOPROTEGERIN LIGAND | DIFFERENTIATION FACTOR | MICE | MARROW STROMAL CELLS | Receptor Activator of Nuclear Factor-kappa B | Membrane Glycoproteins - metabolism | Hodgkin Disease - pathology | Humans | Tartrate-Resistant Acid Phosphatase | RANK Ligand | Reference Values | Glycoproteins - pharmacology | Osteoprotegerin | Acid Phosphatase - metabolism | Membrane Glycoproteins - antagonists & inhibitors | Paraproteinemias - pathology | Time Factors | Isoenzymes - metabolism | Glycoproteins - genetics | Carrier Proteins - antagonists & inhibitors | Glycoproteins - antagonists & inhibitors | Receptors, Cytoplasmic and Nuclear - genetics | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Disease Progression | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Membrane Glycoproteins - genetics | Carrier Proteins - genetics | Animals | Carrier Proteins - metabolism | Receptors, Tumor Necrosis Factor | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Evaluation | Growth | Multiple myeloma | Research | Bone diseases | Risk factors | Tumors | Studies | Genetics | Cells | TRANCE protein | osteoprotegerin
Journal Article
Journal Article